Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
4
pubmed:dateCreated
1995-12-12
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:issn
0390-6078
pubmed:author
pubmed:issnType
Print
pubmed:volume
80
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
295-9
pubmed:dateRevised
2007-11-15
pubmed:meshHeading
pubmed-meshheading:7590496-Animals, pubmed-meshheading:7590496-Bone Marrow Purging, pubmed-meshheading:7590496-Bone Marrow Transplantation, pubmed-meshheading:7590496-Clinical Trials as Topic, pubmed-meshheading:7590496-Fusion Proteins, bcr-abl, pubmed-meshheading:7590496-Gene Expression Regulation, Leukemic, pubmed-meshheading:7590496-Gene Therapy, pubmed-meshheading:7590496-Humans, pubmed-meshheading:7590496-Leukemia, Experimental, pubmed-meshheading:7590496-Leukemia, Myelogenous, Chronic, BCR-ABL Positive, pubmed-meshheading:7590496-Mice, pubmed-meshheading:7590496-Mice, SCID, pubmed-meshheading:7590496-Neoplasm Proteins, pubmed-meshheading:7590496-Oligonucleotides, Antisense, pubmed-meshheading:7590496-Pilot Projects, pubmed-meshheading:7590496-Proto-Oncogene Proteins, pubmed-meshheading:7590496-Proto-Oncogene Proteins c-myb, pubmed-meshheading:7590496-Thionucleotides, pubmed-meshheading:7590496-Treatment Outcome
pubmed:articleTitle
Antisense oligodeoxynucleotides for the treatment of chronic myelogenous leukemia: are they still a promise?
pubmed:publicationType
Clinical Trial, Editorial, Research Support, Non-U.S. Gov't, Clinical Trial, Phase I